Ticker
ORGOCompany Name
ORGANOGENESIS HOLDINGS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Free Cash Flow | Free Cash Flow to Debt | Total Liabilities |
---|---|---|---|
6/30/2025 | $ -46.37M | 0 | $ 99.91M |
3/31/2025 | $ -7M | 0 | $ 99.33M |
12/31/2024 | $ 4.18M | 0.04 | $ 112.57M |
9/30/2024 | $ 3.89M | 0.02 | $ 167.75M |
6/30/2024 | $ 8.52M | 0.05 | $ 179.66M |
3/31/2024 | $ 6.81M | 0.04 | $ 180.45M |
12/31/2023 | $ 6.55M | 0.04 | $ 181.36M |
9/30/2023 | $ -3.59M | 0 | $ 185.78M |
6/30/2023 | $ -19.3M | 0 | $ 179.03M |
3/31/2023 | $ -16.42M | 0 | $ 182.41M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Liabilities
(=) FCF/D
FCF/D for ORGANOGENESIS HOLDINGS INC is calculated as follows: FCF [ $ -41.59M ] / Liabilities [ $ 180.95M ]
(=) FCF/D [ 0 ]
Minimum
Mar 31, 2021
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 2.25K |
---|---|
min | 0 |
max | 0.47 |
average | 0.11 |
median | 0.09 |
std | 0.1 |